Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 6/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | PDE8A | O60658 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.38 |
| ▸ | CDK2 | P24941 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4101363 | 0.90 | YTHDC1 (0.47) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL4095947 | 0.84 | YTHDC1 (0.46) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL4094742 | 0.84 | YTHDC1 (0.48) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL4096821 | 0.81 | YTHDC1 (0.48) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL4097355 | 0.81 | YTHDC1 (0.42) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL5462820 | 0.75 | ADORA2A (0.54) | YTHDC1ADORA2APDE8ACTSLCCNE2 | |
| SCHEMBL3821565 | 0.72 | YTHDC1 (0.57) | YTHDC1ADORA2APDE8AHSP90AB1HSP90AA1 | |
| SCHEMBL4091000 | 0.71 | HSP90AB1 (0.51) | HSP90AB1HSP90AA1KCNH2CYP2C19 | |
| SCHEMBL21801296 | 0.71 | YTHDC1 (0.56) | YTHDC1ADORA2APDE8ACTSLCCNE2 | |
| SCHEMBL30496438 | 0.71 | YTHDC1 (0.56) | YTHDC1ADORA2APDE8ACTSLCCNE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090181989-A1 | Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer | VERNALIS ( R & D) LTD. (GB) | 2009-07-16 | — | — | US | disclosed |
| EP-2004648-A1 | PURINE COMPOUNDS AS HSP90 PROTEIN INHIBITORS FOR THE TREATMENT OF CANCER | Vernalis (R&D) Limited (GB) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007034185-A1 | PURINE COMPOUNDS AS HSP90 PROTEIN INHIBITORS FOR THE TREATMENT OF CANCER | VERNALIS (R & D) LTD. (GB) | 2007-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181989-A1 | Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer | HSP90AA1, HSP90AB1, HSP90AB2P | YTHDC1 1015/4885ADORA2A 1112/4885PDE8A 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.